Helicobacter pylori in children and adolescents: Increase of primary clarithromycin resistance, 1997-2000

Journal of Pediatric Gastroenterology and Nutrition

Volumn 36, Issue 3, 2003, Pages 368-371

  Crone, J ^a   Granditsch, Gerhard ^a   Huber, W D ^a   Binder, C ^b   Innerhofer, A ^b   Amann, G ^c   Hirschl, A M ^d  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c Inst für Klinische Pathologie   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adolescents; Children; Clarithromycin; Helicobacter pylori; Prevalence; Resistance

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PYLORISIN; RANITIDINE BISMUTH CITRATE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHILD; CHRONIC GASTRITIS; DUODENITIS; DUODENUM ULCER; ENDOSCOPY; EROSIVE GASTRITIS; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH ULCER; DRUG COMBINATION; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; PRESCHOOL CHILD;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; NEGIBACTERIA;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; DUODENITIS; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0038363745     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200303000-00012     Document Type: Article

References (25)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
2. Drumm B, Sharman P, Cutz E, et al. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. N Engl J Med 1987;316:1557-61.
3. Suerbaum S, Hur C, Josenhans C, et al. Pathogenesis and virulence factors of Helicobacter pylori. Curr Opin Gastroenterol 1999;15 (suppl 1):11-6.
4. Malfertheiner P, Megraud F, O'Morain C, et al., The European Helicobacter Pylori Study Group. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
5. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. J Pediatr Gastroenterol Nutr 2000;30:207-13.
6. Rowland M, Drumm B. Clinical significance of Helicobacter infection in children. Br Med Bull 1998;54:95-103.
7. Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43:2747-52.
8. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroentemlogy 1998;115:1278-82.
9. Midolo PD, Lambert JR, Turnbridge J. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996;11:290-2.
10. Cayla R. How to eradicate Helicobacter pylori? Gastroenterol Clin Biol 1996;20:119-30.
11. Hirschl AM, Apfalter P, Makristathis A, et al. In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 2000;45:1977-87.
12. Rosenblatt JE. Antiparasitic agents. Mayo Clin Proc 1992;67:276-87.
13. Adamek RJ, Suerbaum S, Pfaffenbach B, et al. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxycillin: influence on treatment outcome. Am J Gastroenterol 1998;93:386-9.
14. Bamford KB, Bickley J, Collins JS, et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. Gut 1993;34:1348-50.
15. Graham D. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterol Clin Biol 1998;115:1272-7.
16. Graham DY, de Boer WA, Tytgat GNJ. Choosing the best anti-Helicobacter pylori therapy. Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:777-81.
17. Kalach N, Bergeret M, Benhamou PH, et al. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J Clin Microbiol 2001;39:394-7.
18. Lopez-Brea M, Martinez M, Domingo D, et al. Evolution of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. Gut 2000;47(suppl 1):A95.
19. Wu H, Shi XD, Wang HAT, et al. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother 2000;46:121-3.
20. Feydt-Schmidt A, Jesch I, Rüssmann H, et al. Primäre Clarithromycin- und Metronidazol-Resistenz von H.pylori-Isolaten in München: 1996-2000. Klin Pädiatr 2001;213:S4.
21. Kalach N, Benhamou PH, Dupont C, et al. Choosing triple therapy for Helicobacter pylori in children: antimicrobial resistance testing of first gastric biopsy culture may predict outcome. J Pediatr Gastroenterol Nutr 2001;32:225-6.
22. Bretschneider D, Wolle K, Leodolter A, et al. Primäre Resistenz von Helicobacter pylori gegen Clarithromycin und Metronidazol bei Kindern und Erwachsenen. Klin Pädiatr 2001;213:S12.
23. Kalach N, Benhamou PH, Dupont C, et al. Helicobacter pylori in children: acquisition of antimicrobial resistance after an initial course of treatment. J Clin Microbiol 2001;39:3018-9.
24. Vergis EN, Yu VL. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. Semin Respir Infect 1997;12:322-8.
25. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group of Antimicrobial Resistance. N Engl J Med 1997;14:441-6.